Subutex 8mg sublingual tablets
2.0 USD
| Min. Order: | 100 Piece/Pieces |
|---|---|
| Trade Term: | CIF |
| Payment Terms: | T/T, WU, Money Gram |
| Supply Ability: | 500000 |
| Place of Origin: | India |
Company Profile
| Location: | Malaysia |
|---|---|
| Business Type: | Manufacturer |
Product Detail
| Means of Transport: | Air |
|---|---|
| Dosage Form: | Tablets |
| Validity: | 36 Months |
| Brand Name: | Subutex 8mg |
| Function: | opioid |
| Subutex 8mg: | sublingual |
| Production Capacity: | 500000 |
| Packing: | discreet and safe |
| Delivery Date: | 3 days maximum |
Product Description
SUBUTEX sublingual tablet is indicated for the treatment of opioiddependence and is preferred for induction. SUBUTEX sublingual tablet should be used as part of a complete treatment plan to include counseling and psychosocial support.
Under the Drug Addiction Treatment Act (DATA) codified at 21 U.S.C. 823(g), prescription use of this product in the treatment of opioid dependence is limited to physicians who meet certain qualifying requirements, and who have notified the Secretary of Health and Human Services (HHS) of their intent to prescribe this product for the treatment of opioid dependence and have been assigned a unique identification number that must be included on every prescription.